2017 FDA New Drug Approvals - JA0008057-0000-19-263-H01-T

2017 FDA New Drug Approvals

by Jill M. O'Donnell, PharmD, BCPS, BCGP
(4.4 / 184 ratings )

This course is credentialed for:
Pharmacy Tech (3.00 Contact Hr)

Price: $33.00
CE-PRO Price: $16.50


Keeping up with the approval of new medications is one of the many challenges of pharmacists and other healthcare providers. As an expert in the field of drug information, a pharmacist plays a vital role in educating patients and other healthcare providers on new medication options. In 2017, the FDA approved 46 new medications to treat a wide variety of disease states, including cancers, multiple sclerosis, and hepatitis C. Many of these new medications will significantly change the way we treat these diseases. This course provides an overview of newly approved medications and their importance to patient care. Specific drug characteristics, the clinical trials that were pivotal to the drugs’ approval, and therapeutic use of drugs are discussed. 


The goal of this course is to educate healthcare professionals on new medications approved by the FDA in 2017. At the end of this course, you will be able to:
  • Identify key novel drugs approved by the FDA in 2017.
  • Discuss first-in-class medications approved in 2017.
  • Describe caveats in current therapy for first-in-class medications.

Accreditation Information
The course is intended for pharmacy technicians
Jointly Accredited Provider logoIn support of improving patient care, OnCourse Learning (a Relias LLC company) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
OnCourse Learning is also approved by the Florida Board of Pharmacy (provider # 50-1489).
Type of Activity: Knowledge
Initial Release Date: 9/11/2019; Planned Expiration Date: 12/31/2019

Course Originally Released on: 9/5/2019
Date of Most Recent Review: 9/5/2019
Course Termination/Update Date: 12/31/2019

Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. Relias LLC guarantees this educational activity is free from bias.

Please see CE Course Instructions to learn how to earn CE credit for this module.


For Florida professionals:

This course completion will be electronically reported to CE Broker as required per Florida Statute 456.025(7). Click here to view your CE Broker transcript and check the status of your CE requirements with a FREE 7-day CE Broker trial subscription. It may take up to 24 hours for the course to appear on your CE Broker transcript.

It is now required that all CE is completed and reported to CE Broker before you renew your license. When you complete continuing education with us, OnCourse Learning will report your hours for you.

Read more about the new license renewal process at AreYouRenewalReady.com and claim your free Basic Account in CE Broker to see what has already been reported for you.

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid FL license number. This information is required for correct reporting of your course completions to CE Broker.

Reports to CE Broker

Sort By
Kiran S - Centreville, VA  ·  Dec 07, 2019
Drugs are too complicated
Was this review helpful?  0
Cody A - Lincoln, CA  ·  Dec 04, 2019
this course was informational
Was this review helpful?  0
Fahar D - oakland , CA  ·  Dec 03, 2019
I would give this course a five stat rating. it was helpful
Was this review helpful?  0
CHRISTIN H - KANSAS CITY, KS  ·  Nov 30, 2019
great course, appreciated being able to take more than once.
Was this review helpful?  0
Rachel M - tallahassee, FL  ·  Nov 28, 2019
way too much information and no common drugs all specialty
Was this review helpful?  0
  Page: of 16  
Price: $33.00
CE-PRO Price: $16.50